Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryRadiology AI company offering Annalise Enterprise and Annalise Triage products for CXR and non-contrast head CT workflows.
Radiology teams that need broad CXR or head CT finding coverage with region-specific regulatory and workflow review.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating annalise.ai as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Separate U.S. triage-cleared findings from broader regional Enterprise feature sets; not all findings, reporting features, or regions have the same status. |
|---|---|
| Privacy | Review DICOM flow, viewer access, cloud or local deployment, audit logs, retention, and customer security documentation before routing imaging studies. |
| Evidence | Evaluate performance by finding, modality, geography, patient population, radiologist workflow, and reporting-time objective instead of treating 100-plus finding coverage as uniform evidence. |
| Workflow | Define whether AI output changes reporting order, draft reports, critical-findings escalation, or second-reader behavior, then monitor alert fatigue and missed findings. |
annalise.ai describes radiology AI products for chest X-ray and non-contrast head CT, including Annalise Enterprise, Annalise Triage, FDA-cleared U.S. findings, CE-marked regional products, worklist prioritization, and draft reporting support.
Not for: General-public purchase, unsupported regions, autonomous diagnosis, or use of non-U.S. features as though they were FDA-cleared.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.